Cannabis Law Report

JANUARY 6, 2022

Oregon’s developing psilocybin program is nothing short of revolutionary and provides an opportunity to investigate the potential of psilocybin in treating a myriad of mental health conditions. An especially worrisome development is the efforts of pharmaceutical companies to patent psilocybin products. By Brett Mulligan.

Access 52

Access Patients Research and Development Treatment 52

Cannabis Law Report

MAY 12, 2022

The new tool lets individual users and businesses connect with the entire Canxchange universe through a public chat feature, and gives them instant access to the company’s sales and support team. Under a limited access “light” version users can network and access data. Two options.

Access 52

Access Research and Development Hemp Data 52

Cannabis Law Report

MAY 29, 2022

is a Canadian company that researches, develops and grows psilocybin-producing mushrooms and functional mushrooms. Ciprick said there needs to be more outcome data and studies on the psilocybin-producing mushrooms to give that comfort level heading forward into introducing a larger market for the product. Optimi Health Corp.

Research and Development 52

Research and Development Clinical Trials Medicine Access 52

Cannabis Law Report

JANUARY 7, 2022

Our NXTecK™ platform is introducing scalable, aggregated, and normalized consumer data with an attribution model, so you know exactly where and how to focus your multi-channel strategies and achieve your digital marketing goals. Free Access to Equio ®. Sponsorship and Marketing Offerings.

Data 52

Data Research and Development Access Retail 52

The Cannigma

JANUARY 16, 2021

When you walk into a hardware store, pharmacy, or even a liquor store, if you don’t know exactly what product will meet your needs there’s someone educated enough to point you to the right product and the data to back up that recommendation, says Tyler Dautrich, COO of Releaf. Edited and mixed by Michael Schaeffer Omer-Man.

Data 100

Data Research and Development Patients Strains 100

Cannabis Law Report

MAY 29, 2022

Earlier this month, Senators Brian Schatz (D-HI) and Cory Booker (D-NJ) sent a letter to the National Institutes of Health (NIH) and the Food and Drug Administration (FDA) urging both agencies to advance research on the therapeutic effects of psychedelic drugs. [1] Recent Regulatory Developments. Challenges.

Research and Development 52

Research and Development DEA Clinical Trials Therapy 52

Cannabis Law Report

JULY 29, 2021

Scientists and researchers do not know exactly how or why these negative results occur, but they are still working on the question. Our main product is the Ehave Telemetry Portal, which is a mental health informatics platform that allows clinicians to make objective and intelligent decisions through data insights.

Research and Development 105

Research and Development Conditions Data Patients 105

Cannabis Law Report

MARCH 9, 2022

This license expansion will further position Numinus as a recognized global research centre for natural psychedelic medicines, and supplements the current work Numinus is already undertaking on Psilocybe species and inherent synergistic compounds. Harmaline and harmalol naturally occur in B. caapi , while P. viridis , D.

Research and Development 52

Research and Development Therapy Access Medicine 52

Cannabis Law Report

JANUARY 31, 2022

TSX-V:NUMI, OTC:LKYSF) said that its research facility– Numinus Bioscience– has been included on Health Canada’s list of federally licensed psilocybin producers. This list is available by request to those seeking access to psilocybin through the Special Access Program (SAP), and clinical researchers.

Research and Development 52

Research and Development Clinical Trials Packaging Access 52

Cannabis Law Report

MAY 14, 2022

One of the largest and arguably sustainable customer bases, however, is consumers with some sort of health or therapeutic need for which they are unable to access medicinal cannabis. One potential consequence of the FSA’s drive to rein in the UK’s CBD industry is reduced access to the previously available wide range of products.

Access 52

Access CBD Research and Development Medicine 52

Veriheal

DECEMBER 9, 2021

Opponents are likely referencing studies that link mental illness to regular cannabis use, even though those studies have been invalidated by research and do not even revolve around legalization. We found that recreational marijuana access was associated with a 6.29 We found that recreational marijuana access was associated with a 6.29

Legalization 98

Legalization Research and Development Consumption Recreational 98

Cannabis Law Report

AUGUST 9, 2022

August 08, 2022 09:30 ET | Source: Allied Market Research. 08, 2022 (GLOBE NEWSWIRE) — According to the report published by Allied Market Research, the global hemp clothing market generated $2.29 Avenue Basic Plan | Library Access | 1 Year Subscription |. … portland, OR, Aug. from 2022 to 2031.The

Hemp 52

Hemp Research and Development Data Business 52

Cannabis Law Report

AUGUST 30, 2021

.–(BUSINESS WIRE)– #cannabis — Dewey Scientific , an agtech innovator pioneering solutions for a sustainable and thriving cannabis industry, announced today the online publication of new data describing the first experimentally validated disease resistance gene in cannabis. Garfinkel, PhD.

Research and Development 103

Research and Development Sativa Agriculture Cultivation 103

Cannabis Law Report

AUGUST 14, 2019

Let’s take a closer look at five key ways big data and technology are directly impacting the industry. Big Data Streamlines the Marijuana Regulatory Process and Helps Close the Scientific Research Gap. Big Data Improves Distribution in the Marijuana Industry. Source: [link]. Global Cannabis Applications Corp.

Data 45

Data Research and Development Marijuana Collective 45

Cannabis Law Report

APRIL 19, 2019

A female CEO of a cannabis research company is fighting back against controversial Marijuana investor Andy Defrancesco after he started a twitter campaign to allegedly disparage her company and her personal ethics as a CEO. Read on at … Sol Global Chairman Andy Defrancesco sued for Defamation by Cannabis Research Firm: $SOLCF.

Research and Development 61

Research and Development Data Media Banking 61

Cannabis Law Report

APRIL 28, 2022

Get a bunch of researchers to research it, publish a report for committees to mull over and then ignore. The researchers leading the study were all affiliated with The University of Queensland , and they examined, “historical changes in legalization attitudes and the period-specific individual and external influences on these.”. “A

Legalization 52

Legalization Research and Development Media Data 52

Cannabis Law Report

JUNE 5, 2021

On Wednesday, Argentina’s Minister of Productive Development, Matías Kulfas , presented a bill titled, “Regulatory framework for the development of the medical cannabis and hemp industry ,” within the framework of the Economic and Social Council. Supplier development: Genetics, agro 4.0, Yahoo Finance reports.

Hemp 105

Hemp Research and Development Pharmaceutical Agriculture 105

MMJ Recs

MARCH 16, 2024

Economic Growth and Job Creation of the medical marijuana industry The medical cannabis sector serves as a catalyst for economic expansion and workforce development in regions where it’s legalized. Additionally, stigma and misinformation surrounding medical marijuana persist, impacting public perception and patient access.

Supply Chain 105

Supply Chain Research and Development Marijuana Seed-To-Sale 105

Cannabis Law Report

NOVEMBER 22, 2019

MMJ International Holdings, the premier medical cannabis research company, announced that it has received DEA approval to ship THC and CBD from Canada. MMJ International Holdings is developing oral drug products from natural whole plant extract derivatives from the marijuana plant containing THC and CBD.

DEA 66

DEA Clinical Trials THC Research and Development 66

Cannabis Law Report

JUNE 16, 2021

Both parties to this new relationship are committed to excellence in clinical research and patient access to psychedelic medicine with a focus on naturally derived psilocybin. As two emergent complementary medicines, many parallels exist between the medical cannabis industry and the currently developing psychedelic medicine industry.

Clinical Trials 104

Clinical Trials Therapy Research and Development Events 104

Cannabis Law Report

JULY 28, 2021

Producing deep-dive policy and operational research and analysis on priority initiatives. Translating complex policy ideas into talking points, emails, briefs, and other publicly accessible communications. Assist in the research, drafting, and creation of policies for the Supervisor.

Policy 105

Policy Legislation Research and Development Data 105

Cannabis Law Report

JUNE 29, 2021

Desai brings to Ehave the ability to visualize opportunities and execute creative strategic solutions, while developing deep networks and relationships within the industry. Research in the area of mental health has been Dr. Nitin Desai’s passion. Ben Kaplan, CEO of Ehave, Inc. Forward-Looking Statement Disclaimer.

Clinical Trials 105

Clinical Trials Research and Development Data Patients 105

The Cannigma

MARCH 14, 2023

Those who were already under close watch by law enforcement because of structural racism, as well as those who were responsible for the well being of others had to be very careful about how they were perceived by those in control of the laws. This included whether they had access to educational information about cannabis.

Policy 96

Policy Research and Development Conditions Consumption 96

The Cannigma

JUNE 14, 2021

For more than 50 years, if you wanted to do cannabis research in the United States, federal law said you had to get the cannabis from the University of Mississippi. We are absolutely ecstatic,” George Hodgin, the CEO of the Castroville, California based Biopharmaceutical Research Co. BRC) told The Cannigma this week.

DEA 133

DEA Research and Development Clinical Trials Pharmaceutical 133

Cannabis Law Report

OCTOBER 13, 2021

Once off-limits because of federal prohibition, a trickle of research from the 1990s has grown into a stream. But despite increasing acceptance by the public, and commercial investment in psychedelic therapies, aging federal laws stem the flow of vital research. An abundance of science and public health data supports it.

Research and Development 52

Research and Development Therapy Access Data 52

Veriheal

DECEMBER 27, 2022

Let’s dive into what the research says about these promising new findings and how they might advance the field of psychedelic research. Some research suggests that these substances could be used to treat mental health conditions like depression and anxiety. The subjective nature of self-reported data can plague research.

Research and Development 95

Research and Development Therapy Consumption DEA 95

Cannabis Law Report

JUNE 1, 2021

The 5-year study is expected to cover tens of thousands of patients suffering from chronic pain, which makes it one of the largest and most ambitious research projects to be conducted in the plant-based treatment arena. has emerged as the largest producer and exporter of legalized cannabis for medical and research applications.

Clinical Trials 89

Clinical Trials Chronic Pain Data Research and Development 89

Cannabis Law Report

JULY 21, 2021

Akerna (Nasdaq: KERN ), an enterprise software, leading compliance technology provider, and developer of the cannabis industry’s first seed-to-sale enterprise resource planning (ERP) software technology (MJ Platform®) today announced the release of its second annual mid-year review. You can access the report here. About MJ Freeway.

Supply Chain 105

Supply Chain Seed-To-Sale Data Research and Development 105

MMJ Recs

NOVEMBER 17, 2023

By legalizing MMJ, the state has facilitated access to a natural and potentially life-changing treatment option for patients suffering from various medical conditions. Promoting Research and Innovation The medical marijuana industry promotes research and innovation in the field of cannabis-based therapies.

Chronic Pain 98

Chronic Pain Therapy Research and Development Treatment 98

Cannabis Law Report

AUGUST 12, 2021

Highlights: Phase IIb COMP360 psilocybin therapy trial for treatment-resistant depression (TRD) close to completion; on track to report data by end of 2021. Partnership being developed with leading UK institutions to accelerate psychedelic research and develop new models of mental health care in the UK. LONDON, Aug.

Clinical Trials 98

Clinical Trials Therapy Research and Development Data 98

Cannabis Law Report

SEPTEMBER 14, 2021

The new Radicle Science-OBX alliance fills an unmet need for rigorous scientific research in the cannabis industry and sets a new gold standard for CBD and minor cannabinoid product development.

Extraction 52

Extraction Research and Development Clinical Trials CBD 52

Cannabis Law Report

JANUARY 12, 2022

Through this collaboration, the NPA and Maya will offer both the education and the technology infrastructure needed to make this possible, ensuring accessibility and safety to all communities. “We The Maya platform empowers psychedelic researchers, providers, and participants to collectively chart psychedelic best practices.

Research and Development 52

Research and Development Therapy Safety Clinical Trials 52

Cannabis Law Report

JULY 6, 2021

Johnson’s primary area of research expertise is the psychopharmacology of medications for treating addictions, and he is well known in the field for his discovery that topiramate, a gamma-aminobutyric acid. July 06, 2021 08:30 ET | Source: Ehave. MIAMI, July 06, 2021 (GLOBE NEWSWIRE) — Ehave, Inc., (OTC ” About Ehave, Inc.

Research and Development 97

Research and Development Wellness and Beauty Clinical Trials Therapy 97

CannaMD

MARCH 24, 2021

Researchers from Temple University sought to find out how recreational marijuana legalization in Washington and Colorado influenced adolescent treatment admissions for cannabis. Over the past two decades, legal access to marijuana across the United States has been steadily increasing. Researchers Jeremy Mennis and Gerald J.

Treatment 104

Treatment Legalization Marijuana Research and Development 104

Cannabis Law Report

JULY 20, 2021

With our new psychedelic medicinal insurance solutions, business can access the necessary coverages to protect their business, attract qualified officers/directors, and bring new treatments to market.”. Complicating matters, each state has their own set of laws, which are rapidly evolving. Eric Rahn, Managing Director.

Medicine 98

Medicine Business Research and Development Chronic Pain 98

Cannabis Law Report

JANUARY 17, 2022

We are seeing increased numbers of trials and studies advancing these compounds along the drug development pipeline, but there has been relatively little focus on how these molecules will be reliably produced at a large scale. “We’re very pleased with Telescope’s research results this year,” added Hein.

Research and Development 52

Research and Development Pharmaceutical Access Medicine 52

Cannabis Law Report

JULY 20, 2022

NEW YORK , July 19, 2022 /PRNewswire/ — Data Bridge Market research has recently released expansive research titled “ Global Cannabis Seeds Market ” guarantees you will remain better informed than your competition. Recent Developments. million in 2021 and is expected to reach USD 5,694.95

Seed-To-Sale 52

Seed-To-Sale Research and Development Ruderalis Data 52